metastatic gastric cancer,
Showing 1 - 25 of >10,000
Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,
Recruiting
- Metastatic Gastric Cancer
- +2 more
- Nivolumab
- +2 more
-
New York, New YorkBureau for Cancer Research
May 10, 2023
Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab
Recruiting
- Metastatic Gastric Cancer
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- Nivolumab Injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Aug 23, 2023
Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2023
Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)
Not yet recruiting
- Gastric Cancer
- RC48-ADC
- +4 more
-
Beijing, ChinaBeijing Cancer Hospital
Aug 7, 2023
Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)
Recruiting
- Breast Cancer
- +5 more
- 89Zr-DFO*-trastuzumab PET scan
-
Amsterdam, Noord-Holland, NetherlandsAmsterdamUMC
Jul 12, 2023
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
Metastatic Gastric Cancer, Surgery, Chemo Trial (Palliative surgery after translational therapy, Chemotheraoy along)
Not yet recruiting
- Metastatic Gastric Cancer
- +2 more
- Palliative surgery after translational therapy
- Chemotheraoy along
- (no location specified)
Mar 30, 2022
HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)
Recruiting
- HER2-positive Gastric Cancer
- Immunotherapy
- Disitamab Vedotin combined with fruquintinib and Tislelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 8, 2023
Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)
Not yet recruiting
- Metastatic Lung Cancer
- +2 more
- Tusamitamab ravtansine
-
Rotterdam, NetherlandsErasmus MC
Jan 26, 2023
Gastric Cancer Trial in Shanghai (Apatinib)
Completed
- Gastric Cancer
-
Shanghai, Shanghai, ChinaShanghai 6th People's Hospital
Feb 24, 2022
Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer Trial in New Taipei City, Taipei
Completed
- Metastatic Gastric Cancer
- +3 more
-
New Taipei City, Taiwan
- +3 more
Sep 21, 2022
HER2-positive Gastric Cancer Trial (HLX10, Trastuzumab and Chemotherapy)
Not yet recruiting
- HER2-positive Gastric Cancer
- HLX10, Trastuzumab and Chemotherapy
- (no location specified)
Mar 28, 2022
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Camrelizumab,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Camrelizumab
- Apatinib Mesylate
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Apr 16, 2022
Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)
Active, not recruiting
- Stomach Neoplasms
- +2 more
- Atezolizumab
- +3 more
-
Beijing, China
- +10 more
Dec 21, 2022
Gastric Cancer Trial in Seoul (Variltinib, Paclitaxel)
Active, not recruiting
- Gastric Cancer
- Variltinib, Paclitaxel
-
Seoul, Korea, Republic ofYonsei University Health System, Yonsei Cancer Center
May 27, 2022
Gastric Cancer Trial in Seoul (Apatinib mesylate)
Completed
- Gastric Cancer
- Apatinib mesylate
-
Seoul, Songpa-gu, Korea, Republic ofAsan medical center
Jul 20, 2022
Metastatic Gastric Cancer Trial in Zhengzhou (fruquintinib+toripalimab + SOX)
Recruiting
- Metastatic Gastric Cancer
- fruquintinib+toripalimab + SOX
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Aug 17, 2022
Stomach Cancer Trial in Beijing (KN026/Placbo Injection, Paclitaxel Injection, Docetaxel Injection)
Recruiting
- Stomach Cancer
- KN026/Placbo Injection
- +3 more
-
Beijing, ChinaChinese PLA General Hospital
Jun 16, 2022
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Wuwei, Shanghai (HLX07+HLX10+oxaliplatin+capecitabine,
Recruiting
- Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
-
Wuwei, Gansu, China
- +1 more
Apr 25, 2022
Gastric Cancer Trial in Seoul (pembrolizumab plus ramucirumab)
Recruiting
- Gastric Cancer
- pembrolizumab plus ramucirumab
-
Seoul, Korea, Republic of
- +1 more
Feb 23, 2022
Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)
Recruiting
- Hepatocellular Carcinoma
- +6 more
- Embolization
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023